
Dopamine receptors D3 and D5 regulate CD4 +T-cell activation and differentiation by modulating ERK activation and cAMP productionDopamine receptors D3 and D5 regulate CD4 +T-cell activation and differentiation by modulating ERK activation and cAMP production
PROCEDENCIA(S): | Ciencia y Medicina. |
---|---|
CATEGORÍA(S): | Inmunología, Neurociencias, Neurología Clínica. |
AUTOR(ES): | Dafne Franz / Francisco Contreras / Hugo González / Carolina Prado / Daniela Elgueta / Claudio Figueroa / Rodrigo Pacheco. |
TIPO DE MATERIAL: | Artículos. |
ARCHIVO: |

Dopamine receptors have been described in T-cells, however their signalling pathwayscoupled remain unknown. Since cAMP and ERKs play key roles regulating T-cellphysiology, we aim to determine whether cAMP and ERK1/2-phosphorylation are modulated by dopamine receptor 3 (D3R) and D5R, and how this modulation affectsCD4+ T-cell activation and differentiation. Our pharmacologic and genetic evidence shows that D3R-stimulation reduced cAMP levels and ERK2-phosphorylation, consequently increasing CD4+ T-cell activation and Th1-differentiation, respectively. Moreover, D5R expression reinforced TCR-triggered ERK1/2-phosphorylation and T-cell activation. In conclusion, these findings demonstrate how D3R and D5R modulate key signalling pathways affecting CD4+ T-cell activation and Th1-differentiation.